Drug intelligence / Profile preview

ACH04

Development stage: Phase 1
Modality: Small Molecules
Administration: Oral

Overview

ACH04 is an investigational drug that has undergone a phase I clinical trial to assess its safety and tolerability in healthy adults. The available information indicates it is being developed for the treatment of diarrhea, with repeated oral dosing studied in humans[1][2]. Details on its mechanism of action, chemical structure, or specific molecular target are not publicly disclosed. No brand names or alternative names have been reported.

Beyond the preview

Go deeper on ACH04.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACH04.

Explore the full profile